AZTherapies, Inc.
Quick facts
Phase 3 pipeline
- ALZT-OP1a · Neurology
ALZT-OP1a is a small molecule that modulates tau pathology and neuroinflammation to slow cognitive decline in Alzheimer's disease. - ALZT-OP1b · Neurology
ALZT-OP1b is a small molecule that modulates tau pathology and neuroinflammation to slow cognitive decline in Alzheimer's disease.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: